Eliminating alloreactive cells from T-cell populations would enable the transfer of immune function to patients who receive stem cell transplants. However, highefficiency depletion has proved difficult to achieve. We sought to develop ex vivo approaches for the maximal depletion of alloreactive CD4 ؉ T cells. Using a flow cytometric cell sorting approach after mixed lymphocyte reaction (MLR) culture, we have found that sorted CFSE bright (5-(and-6)-carboxyfluorescein diacetate succinmidyl ester) (nondivided) and activation antigen-negative cells are markedly depleted of alloreactivity. With HLA-mismatched peripheral blood mononuclear cell (PBMC) stimulators we have consistently attained (90%-95%) depletion of alloreactivity. Importantly, when purified matured monocyte-derived dendritic cells (DCs) are used as stimulators, a 100-fold (99%) reduction in alloreactivity was attained, resulting in abrogation of the secondary MLR. Significantly, the CFSE bright CD25 ؊ cells recovered from these cultures retained general immunoreactivity, including responses to Candida and cytomegalovirus (CMV) antigens. In addition, a CFSE-based approach was tested and found to be sufficient for graft-versus-host disease (GVHD) prevention in vivo, in a major histocompatibility complex (MHC) class II disparate murine model. This efficient approach to selectively deplete mature alloantigen-specific T cells may permit enhanced immune reconstitution without GVHD. (Blood.
Introduction
Clinically, it is desirable to develop a method that allows the adoptive transfer of mature T cells to bone marrow transplant (BMT) or to immunodeficient patients. This transfer would provide general immunocompetence and the potential to fight off infection as well as to provide antitumor reactivity. However, T-cell infusions contain alloreactive cells capable of causing graft-versus-host disease (GVHD). GVHD remains a severe problem in BM transplantation, and it greatly restricts the use of this therapy. [1] [2] [3] [4] The GVHD-causing antihost alloreactive cells constitute a minor subset of the total T-lymphocyte population (Ͻ 0.1% for HLA-matched sibling transplantation; 1%-5% for HLA-mismatch setting), and their complete elimination is difficult. 5 Although rigorous pan T-cell depletion of a BMT graft can markedly reduce the incidence and severity of GVHD, problems with poor engraftment and delayed immune reconstitution may offset clinical benefit. 6, 7 Thus, methods for the specific elimination of just the alloreactive subset of T cells are highly desirable.
Several methods for alloreactive T-cell depletion have been reported. These methods primarily use the targeting of activation antigens, the expression of which is induced ex vivo on the surface of alloreactive T cells after stimulation in allogeneic mixed lymphocyte reaction (MLR) cultures. Anti-CD25 and interleukin 2 (IL2) fusion immunotoxin, [8] [9] [10] anti-CD25, anti-CD69, or both combined magnetic bead depletion, [11] [12] [13] [14] or fluorescence activated cell sorting (FACS)-based 15 approaches have been used to selectively remove the MLR-activated cells. More recently, there have been reported approaches based on killing activated T cells, by Fas-mediated apoptosis induction, 16 or by a phototoxic dye-based strategy, which selectively accumulates in activated T cells. 17 Although it is hard to quantitatively compare the approaches, these methods have yielded roughly 70% to 95% reductions in alloreactivity in vitro, importantly with retention of third-party alloreactivity and anti-infectious responses. Several studies have revealed retained specific in vitro antileukemia reactivity. 10, 17, 18 Studies have also been done to show reduced GVHD potential of allodepleted cells in vivo in mouse models with immunotoxin strategies 19 or with magnetic bead depletion. 20 The immunotoxin strategy has been taken to clinical trial in haploidentical patients receiving BMTs, in which donor peripheral blood mononuclear cells (PBMCs) were cultured with recipient PBMCs, with results suggesting that small numbers of allodepleted cells can be transferred safely with possible augmentation of immune reconstitution. 21 Importantly, there was a correlation of residual alloproliferative response (as assessed by residual primary MLR) and GVHD. 21 In aggregate, these studies show the potential of allodepletion to allow for the transfer of small numbers of T cells; however, the degree of alloreactivity reduction remains incomplete.
To further investigate the biology of T-cell alloresponses, we used a cell permeant fluorescent dye to label responder T cells. 22, 23 Using this approach, we can identify and track both dividing alloreactive cells (CFSE dim ) (5-(and-6)-carboxyfluorescein diacetate succinmidyl ester) and nondividing T cells (CFSE bright ) by FACS and assess the function of both populations of cells by using the cell sorter to physically separate them. In this study, we evaluated the hypothesis that functional sorting of nonalloreactive cells, based on nondivision (CFSE bright ), would deplete GVHDinducing cells. We found that CFSE sorting was sufficient to markedly decrease disease. We also found that depletion of alloreactivity as assessed by in vitro methods could be further enhanced by combing activation antigen selection and using potent purified antigen-presenting cells (APCs). Using this strategy with human CD4 ϩ T-cell responders, we found that small, resting, CFSE bright , and CD25 Ϫ cells, isolated from dendritic cell (DC)-driven MLR cultures, had no detectable secondary alloresponse in most donor combinations. Importantly, the sorted nonalloreactive cells retain third-party alloreactivity and immune responses to Candida and cytomegalovirus (CMV) antigens. In contrast, use of PBMC stimulators (even in high numbers) was found to be inefficient for allodepletion. In addition, proof of principle for the biologic efficacy of CFSE-based elimination of GVHD-causing T cells was obtained in vivo in a murine major histocompatibility complex (MHC) class II disparate model system. In these experiments, sorting solely on CFSE bright cells after in vitro MLR culture was able to markedly reduce GVHD incidence.
Materials and methods

Isolation of responder and stimulator cells for MLR cultures
CD4 ϩ T cells were isolated from buffy coat preparations derived from the whole blood of healthy volunteer donors (Memorial Blood Centers, Minneapolis, MN). Leukocyte-rich buffy coat cells were centrifuged over Ficoll-Hypaque layers to collect PBMCs. CD4 ϩ T cells were isolated by positive selection with anti-CD4 magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were routinely 96% to 98% pure by FACS analysis. DCs were generated from CD14 ϩ monocytes, 24, 25 isolated from PBMCs, by magnetic bead-based purification (Miltenyi-Biotec) and were cultured in X-vivo-15 (BioWhittaker, Walkersville, MD) media at 1 ϫ 10 6 cells/mL supplemented with granulocyte-macrophage colonystimulating factor (GM-CSF; 50 ng/mL final) and IL4 (20 ng/mL final) cytokines (R&D Systems, Minneapolis, MN). Cells were cultured for 1 week and then matured with tumor necrosis factor ␣ (TNF␣; 25 ng/mL final) and Poly I:C (25 g/mL final) (Sigma, St Louis, MO) for 2 days. 26, 27 Poly I:C (polyinosinic polycytidylic acid) is a synthetic molecule that acts as a double-stranded RNA (dsRNA) analog, which activates APCs through binding to TLR-3 (Toll-like receptor 3), 28 which monocyte-derived dendritic cells have been shown to express abundantly. 29 PBMCs and DC stimulators were irradiated at 30 Gy.
MLR cultures
CFSE-labeled responding CD4 ϩ T cells (20 ϫ 10 6 ) and 40 ϫ 10 6 PBMCs or 3.5 ϫ 10 6 DC stimulator APCs were cultured in T25 flasks in 20 mL media. Culture media was RPMI-1640 (Gibco-Life Technologies, Grand Island, NY) supplemented with 10% human AB serum (PelFreeze, Brown Deer, WI), L-glutamine, penicillin, and streptomycin. After 7 days cells were centrifuged over Ficoll-Hypaque to collect viable cells and were stained with anti-CD25-PE (phycoerythrin) clone M-A251 (BD Pharmingen, San Diego, CA). Cells were sorted on a Vantage Flow Cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA).
CFSE labeling and analysis
CD4 ϩ T cells were labeled with 2.5 mol/L CFSE (Molecular Probes, Eugene, OR) for 10 minutes at 20°C in phosphate-buffered saline (PBS; 0.1%) bovine serum albumin (BSA) buffer. Flow cytometric data were analyzed by CellQuest (Becton Dickinson) and Flojo software. Proliferative analysis and precursor frequency quantitation was also by Flojo software version 3.6 (Treestar, San Carlos, CA). Precursors, which give rise to proliferating T-cell blasts, can be quantitated by summing the number of cells in each peak and dividing by 2 to the power of the cell division number, ie, for cells in the eighth peak that have divided approximately 8 times (2 8 ϭ 256), 256 cells have derived from one precursor. 22, 23 Secondary MLR cultures T-cell populations after primary MLR or FACS sorting were recultured in secondary MLR. Responders (10 4 , 5 ϫ 10 4 , or 10 5 ) were cultured with 10 5 frozen/thawed, centrifuged over Ficoll layers, and irradiated PBMC stimulator preparations from the same donor as the initial MLR. Third-party MLR used identical conditions with unrelated donor PBMCs. Sorted CFSE bright or nonactivated (NA) cells alone had no counts above background. Primed cells alone had some residual proliferation, which was exhausted after 2 to 3 days, and these background counts were subtracted out of data shown. Cells were cultured in 96-well round-bottom plates and were pulsed daily for 7 days with 3 H-thymidine on the last 16 hours of culture. Each time point had 6 replicates. Cells were harvested with 96-well plate harvester, and dried filters were counted with a direct beta counter with no liquid scintillation amplification. Counts are lower but proportionally accurate.
Antimicrobial responses
Fresh and sorted CD4 ϩ T cells (10 5 ) were cultured with 10 5 frozen/thawed autologous CD4 Ϫ PBMCs in 96-well round-bottom plates. Candida antigens were added at 10 g/mL (Greer Labs, Lenoir, NC), and CMV lysate was added at 1/100 dilution (Microbix, Toronto, Canada). The no antigen controls had minimal background counts, which were subtracted away from data shown. Cultures were pulsed with 3 H-Thymidine on day 7.
Limiting dilution analysis (LDA)
Populations of CD4 ϩ T cells, either fresh or sorted, were tested for their proliferative capacity at limiting numbers by plating at 3 ϫ 10 4 cells per well (96-well plates) with 24 replicates per concentration and serial 1/3 dilutions. 30 All cells were cultured for 8 days with 5 ϫ 10 4 PBMCs irradiated to 30 Gy. No IL2 was added to the media. On serial dilution of responding T cells, the dilution at which 37% of wells are nonreactive represents the concentration at which approximately one alloreactive progenitor/well is present (using a poisson distribution). 30 Wells with counts more than 3 standard deviations above background were scored as positive. With the DC system, X-vivo-15 medium was used, which led to slightly increased LDA frequencies.
Elispots
Polyvinylidene diflouride (PVDF) 96-well plates, MAIPS45 (Millipore, Bedford, MA) were coated with anti-interferon ␥ (IFN-␥) antibody at 10 g/mL overnight (Mabtech, Nacka, Sweden). Plates were washed, and 10 5 fresh or sorted T cells were added with 10 5 allogeneic PBMCs. Plates were then incubated for 2 hours with biotin-anti-IFN-␥ antibody (Mabtech). Avidin-Peroxidase-Complex (Vector Labs, Burlingame, CA) was added for 1 hour at room temperature, and spots were developed with 3-amino-9-ethylcarbazole (AEC) substrate (Vector Labs). Spots from triplicate wells were counted with an Elispot reader (Zeiss).
Mice
B6.C-H2bm12/KhEg (termed bm12) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). C57BL/6 mice were purchased from the National Institutes of Health (Bethesda, MD). C57BL/6 and bm12 (both H2 b ) mice differ at 3 amino acids because of mutations in the MHC class II IA region. Mice were used at 8 to 12 weeks of age and were housed in a specific pathogen-free facility in microisolator cages.
In vitro murine MLR cultures
CD4 ϩ T cells were purified from peripheral lymph nodes by Cellect mouse CD4 columns (Cedarlane, Hornby, ON, Canada). The final composition of purified T cells was determined by flow cytometric analysis to be more than 94% CD4 ϩ T cells. Responder C57BL/6 CD4 ϩ T cells were incubated with 1 mol/L CFSE for 5 minutes at room temperature. C57BL/6 CD4 ϩ T cells were mixed with irradiated (30 Gy) T-cell-depleted bm12 splenic stimulators. 31 Responder and stimulator cells were suspended at a final concentration of 0.5 ϫ 10 6 /mL in 24-well plates (Costar, Acton, MA) containing Dulbecco modified Eagle medium (DMEM; BioWhittaker) with 10% fetal bovine serum (FBS; HyClone, Logan, UT), 50 mM 2-mercaptoethanol (2-ME; Sigma), 10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) buffer, 1 mM sodium pyruvate (Life Technologies, Grand Island, NY), and amino acid supplements (1.5 mM L-glutamine, L-arginine, and L-asparagine) (Sigma) and antibiotics (penicillin, 100 U/mL; streptomycin, 100 mg/mL; Sigma). After 8 days of culture, live-gated CD4 ϩ cells were sorted into CFSE bright and CFSE dim fractions.
GVHD induction
The bm12 recipients were sublethally irradiated by exposing mice to 6 Gy total body irradiation from a 137 Cesium source at a dose rate of 85 cGy/min. Three hours after irradiation, mice were infused with a uniformly lethal dose (3 ϫ 10 5 cells) of cultured sort-control, CFSE bright , or CFSE dim cells, and survival was monitored.
Statistics
All error bars represent one standard deviation above and below the mean. A paired, 2-tailed Student t test was used to determine the statistical significance of differences between LDA groups and proliferative responses. Survival data were analyzed by life-table methods, and actuarial survival rates are shown. Group comparisons were made by log-rank test statistics. Values of P Ͻ .05 were considered significant.
Results
CFSE-based elimination of human MLR alloreactivity
CFSE labeling of responding T-cell populations has been used to quantitate alloreactivity. By enumerating the subset of cells that have diluted out the dye because of cell division, responding cell precursor frequencies can be calculated. However, the nondividing CFSE bright T cells have not been characterized. We sought to evaluate these nondivided cells and hypothesized that they would be depleted of functionally alloreactive cells. To test this hypothesis, CFSE bright cells were isolated by cell sorting after culture in an allo-MLR and analyzed for residual alloreactivity. We found that under multiple conditions tested, a one log 10 reduction in alloreactivity was readily attainable.
To evaluate reactivity in an allo-MLR culture, highly purified CD4 ϩ responding cells were labeled with the cytoplasmic dye CFSE, cultured with HLA-mismatched allogeneic stimulators, and assessed by flow cytometric analysis. Alloreactive cells undergo activation during days 1 to 3 and a proliferative burst during days 4 to 6. The alloreactive cells undergo multiple rounds of cell division which dilute out the CFSE dye, with at least 8 cell divisions discernible. There is a wide separation of the CFSE dim proliferating cells and the CFSE bright nondividing cells. When high numbers of PBMCs are used as stimulators in this system, with a 1:2 responder cell-stimulator cell (R/S) ratio, a vigorous MLR results ( Figure 1A ).
Under these conditions, after 7 days of culture, about 33% of the responding T cells are blasts. These cells have derived from exponential expansion of the small alloreactive subset of responder T cells. The frequency of alloreactive precursors that gives rise to this cohort of blasts is estimated by quantitative evaluation of the CFSE profile. This determination indicates approximately 1% of the initial T-cell population is recruited to cell division ( Figure 1A ). This number has proved to be relatively consistent under these conditions, with the average (1.1%) for 8 separate experiments (range, 0.5%-1.7%). The CFSE bright cells are derived from the more than 98% of cells that have not divided.
FACS experiments were undertaken to evaluate the secondary MLR responses of the purified CFSE dim blasts and the CFSE bright nondivided cells. Sorted blasts mount extremely quick secondary responses, and their contribution to secondary MLR occurs early (Figure 2A ). Although the CFSE bright cells showed much reduced alloresponses, there appeared to be some residual alloreactivity. Some or all of this alloreactivity may be due to residual blasts in the CFSE bright sorted population, note the early proliferation in the secondary MLR.
To further improve the efficiency of depletion of nonalloreactive cells we added selection against activation antigen expression. Two-color flow cytometric evaluation of CFSE-labeled MLRactivated cells revealed most all of the CFSE dim T-cell blasts to express CD25, and most all of the CFSE bright cells to lack expression of this activation antigen ( Figure 1C ). However, a subset of the nondivided CFSE bright cells also expresses the activation antigen CD25 (approximately 5% of nondivided cells). It was unclear if this population represents alloreactive cells that are about to divide (impending blasts) or anergic CD25 ϩ cells (possibly suppressor cells) that will not go on to divide.
To determine whether the sorted CFSE bright cells or CFSE bright CD25 Ϫ cells (NA, nonactivated cells) were the most allodepleted, we sorted both populations from the same 7-day MLR cultures. The sorted NA cells were a higher purity population and had less residual dividing blast cells. In addition, in secondary MLR cultures, the NA cells were the least reactive. The NA cells had undetectable responses early, and only at late time points did they mount small weak responses (Figure 2A ). This result is consistent with marked depletion but also with the presence of very small numbers of alloreactive cells, which appear to have not become activated in primary culture. As noted earlier, the sorted CFSE bright cells had weak early and sustained secondary MLR responses, consistent with the presence of small numbers of primed cells or impending blasts (Figure 2A) . Because of the presence of CD25 Ϫ CFSE dim alloreactive cells, we did not sort solely on the basis of CD25 selection alone, reasoning that these cells would not be depleted.
To quantify the degree of alloreactivity present in the purified CD4 ϩ T-cell populations, both before and after the sorting procedure, LDA frequencies were assessed ( Figure 2B 
In addition, the CFSE bright and CD25 ϩ cells were also sorted directly and were found to have only small amounts of alloreactivity, with LDA frequencies approximately 1/1700. This frequency is much less than the primed blasts, or even fresh cells, and hence these cells do not contribute much to total residual alloreactivity of CFSE bright cells. However, they do contribute some alloreactive cells. Thus, for maximum depletion of alloreactive cells as assessed by in vitro secondary MLR assay, we favored a combination approach, using both CFSE and CD25 selection.
DC stimulators facilitate elimination of alloreactivity
Despite the efficient multiparameter selection approach, which resulted in highly purified small, nondivided, and activation antigen-negative cells, some residual alloreactivity was retained. This finding suggested that there was incomplete activation of all potentially alloreactive cells. Thus, we sought to determine whether DC would provide a better APC population capable of enhanced recruitment of alloreactive cells. Using the same system as described earlier only substituting DCs as APCs (versus PBMCs) and testing sorted cells in secondary MLR, we determined DCs were at least 5-fold better for depleting alloreactive cells from MLR cultures.
DCs are the most potent APCs for activating naive T cells, as they express abundant MHC alloantigens and high levels of costimulatory molecules and have been shown to optimally activate alloreactive T cells. 32 DCs can be readily generated from peripheral blood monocytes cultured with the cytokines GM-CSF and IL4. These cells are immature DCs and can be further matured and activated with TNF/poly I:C. [26] [27] [28] [29] The matured DCs induced strong and prolonged primary MLR and, compared with PBMC-driven MLR, induced more blast accumulation at the end of culture; approximately 66% of responding cells are blasts ( Figure 1B) .
CFSE-based precursor frequency analysis indicates that approximately 5% (range, 3.1%-6.5%) of the CD4 ϩ T cells are recruited into cell division by the mature DCs. This finding contrasts with the PBMC-stimulated MLR in which approximately 1% of T cells are recruited to cell division. This has been a consistent finding from 8 donor combinations (P Ͻ .0001).
The responder frequency can vary with R/S ratio, whereby higher numbers of DCs lead to an increase in the percentage of CD4 ϩ T cells being recruited to cell division. Titration experiments indicate a plateau in recruitment at approximately an 8:1 R/S ratio. Thus, we used a relatively high 6:1 R/S ratio for bulk culture experiments to maximize alloantigen exposure. 
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For DC-driven alloelimination, CFSE-labeled CD4 ϩ T cells were cultured with activated DCs for 7 days. Recovered cells were stained with CD25 and sorted by FACS for small CD25Ϫ and CFSE bright cells (NA cells) or for large CD25 ϩ CFSE dim primed cells ( Figure 3A ). NA cells after the sort evidence very high purity, generally more than 99.7% CFSE bright and CD25 Ϫ ( Figure 3B ).
By using this protocol, secondary MLR kinetic analysis with sorted NA cells revealed a complete abrogation of secondary MLR ( Figure 4A ). There were no late responses detected in 12 donor combinations. As a further assessment of magnitude of allodepletion, secondary MLR with higher numbers of responders were evaluated. In 10 of 10 donors, no response was noted for 3 ϫ 10 4 responder cells/well in secondary MLR, and in 6 of 8 donors no responses were noted for 10 5 responder cells/well ( Figure 5B ). This degree of allodepletion was not attained with PBMC stimulator experiments.
For the DC series of experiments, we determined LDA frequencies for 4 of the donors, and they were found to be approximately 1/350 ( Figure 4B) . Thus, by comparison of a pretreatment MLR response detectable with less than 500 cells ( Figure 5A ) and a nondetectable response after treatment with more than 5 ϫ 10 4 cells, we have generated T-cell populations with a more than 100-fold (Ͼ 99%) reduction in alloreactivity.
As a separate indicator of allodepletion, interferon-␥ ELISPOTS were determined for 2 donor MLR combinations. CD4 ϩ T cells were tested on primary stimulation and found to have approximately 170 spots/10 5 cells. After allodepletion, only a background level of spots was present (Ͻ 5/10 5 cells).
Retention of immune responsiveness
To determine retained potential for immunologic responsiveness, the CFSE bright NA cells were challenged with third-party allogeneic stimulators. These third-party MLRs displayed primary kinetics (peak day 7) consistent with naive cells (Figure 6A ). Responses of low numbers of cells, 10 4 /well, appeared intact and comparable to that of 10 4 fresh CD4 ϩ T-cell MLRs. To more accurately quantitate the retained third-party reactivity, LDA from 4 donors was assessed. These assays yielded frequencies of (approximately 1/900), similar although slightly diminished to those determined for fresh primary CD4 LDA frequencies (approximately 1/350) ( Figure 4B ) (P ϭ .05).
The sorted NA cells also retained responses to infectious antigens. Proliferative responses to Candida antigens and CMV lysates were well preserved ( Figure 6B ). These results indicate that sorted CFSE bright NA cells are not globally hyporesponsive and they retain functional capability.
Prevention of GVHD in vivo
To determine whether CFSE bright sorted cells were depleted of in vivo GVHD-causing cells, we tested the CFSE-based sorting approach in a class II disparate mouse model. The B6-bm12 transplantation system is a well-characterized model of in vivo alloreactivity, 31 wherein adoptive transfer of as few as 10 4 freshly isolated CD4 ϩ T cells can cause lethal GVHD in approximately 50% of recipients. The sublethally irradiated recipients will recover on their own unless the adoptively transferred cells cause a GVHD-mediated bone marrow aplasia with a short latency. The mouse experiments used a simplified translational protocol whereby T-cell and natural killer (NK) cell-depleted splenocytes were used as APCs, and the postculture sorting was solely selected on the basis of CFSE bright cells ( Figure 7A ). These are vigorous MLRs, and after 7 days about 67% of the remaining T cells are blasts. Calculation of precursor frequency yields an initial alloreactive dividing fraction of approximately 3% (4% and 1.7% in 2 separate experiments). With this protocol, and transferring 3 ϫ 10 5 sorted CFSE bright cells, 70% of mice survived long term, whereas controlsorted CFSE-labeled cells or CFSE dim cells were uniformly lethal ( Figure 7B) . Interestingly, the CFSE precursor frequency correlated with in vivo outcome, in that in the first cohort 7 of 8 mice survived (frequency 4%) and in the second cohort 4 of 8 (frequency 1.7%). Importantly, the surviving mice had no signs of morbidity, as evidenced by normal weights, hematocrits, and lack of skin or gut involvement. These studies demonstrate the potential of the method to allow for the transfer of allogeneic T cells.
Discussion
In this study we evaluated CD4 ϩ T-cell MLR reactivity and determined factors important for activation of alloreactive cells and recruitment to cell division. We also describe an allodepletion technique based on the combined use of a CFSE parameter to aid in the functional selection of nonalloreactive cells (by nondivision) and activation antigen selection. Using this CFSE/cell sorter-based selection method and secondary MLR as a stringent assay, we For personal use only. on November 19, 2017 . by guest www.bloodjournal.org From determined that the use of purified DCs was critical for highefficiency elimination of alloreactive cells in human MLR. Use of this strategy has enabled a more than 2 log 10 reduction in alloreactivity, as assessed by an abrogation of secondary MLR. These allodepleted cells retain immune responsiveness to third-party alloantigens, Candida antigens, and CMV antigens. In addition, we have been able to demonstrate markedly reduced in vivo disease causing potential of CFSE bright sorted cells in an MHC class II disparate murine model of GVHD.
We began these studies with the idea to use CFSE labeling as an analytical tool to evaluate T-cell alloreactivity. We hypothesized from these studies that sorting on the basis of the CFSE parameter might lead to effective purification of functionally nonalloreactive cells. The selection is based on a functional readout of cell division, and hence the most aggressive division-prone cells should be most efficiently eliminated. There is a wide separation of the CFSE bright resting and CFSE dim alloreactive dividing cells, and this separation allows for highly efficient sorting. In addition, the CFSE parameter also allows for the elimination of alloreactive cells regardless of their expression of activation antigens. We find that frequently there are small populations of alloreactive cells that do not express activation antigens such as CD25 (or CD69, CD71, or CD134) and, thus, are unavailable for activation antigen-based approaches for depletion. The only requirement for selection on the basis of the CFSE parameter is recruitment to cell division. The fact that this technique can be used to deplete alloreactive T cells that may be sufficient for GVHD prevention is supported by our murine data using spleen cell populations that proved to be potent APCs. CFSE sorting of T cells in murine MLR cultures lead to reduced GVHD lethality. Although we favor the explanation that the inhibition of GVHD was due to allodepletion, we did not directly measure donor T-cell persistence because of the small number of donor T cells transferred and the fact that the vast predominance of T cells are of host origin in this sublethal total body irradiation (TBI) model. However, host T cells cannot reject donor T cells because neither resting nor activated donor T cells are capable of expressing MHC class II antigens. 32, 33 Because the CFSE parameter requires a FACS sorter, we also took advantage of other parameters during sorting to enhance the selection of nonalloreactive cells in the human system. Small cell size and lack of activation antigen expression were also used to enhance sorting efficiency and allodepletion in vitro. In theory, this multiparameter sorting method could provide enhanced GVHD protection in the murine system.
Of interest, we do find a small population of activation marker (CD25 ϩ ) positive CFSE bright (nondivided) cells. These cells constitute about 5% of the CFSE bright cells in the human MLR. This population appears to contain anergic CD4 ϩ CD25 ϩ cells, as well as variable numbers of alloreactive cells. By LDA, these cells have less alloreactivity than fresh cells, especially at later time points in MLR (day 7-8). Thus, this population may contain some alloreactive cells about to divide, but the majority appears to be poorly capable of dividing. The potential suppressor function and in vivo relevance to GVHD induction of this population are the subjects of ongoing investigation. However, because of the small amount of known alloreactivity, we favored adding activation antigen depletion to the selection protocol.
We have compared the sorting method with an immunotoxin (DT-IL2)-mediated depletion in the PBMC-stimulated system. In 4 of 4 donor combinations, the sorting approach yielded cell populations with 2-to 3-fold less secondary alloreactivity and better retention of third-party reactivity (W.R.G. and M.R.K., unpublished data, October 2001). In addition, we have compared the sorting approach directly with an anti-CD25 magnetic microbead-based depletion in the DC system. In 3 of 3 donor combinations, the bead-based approach did not eliminate secondary MLR reactivity with 10 5 responder cells. Exhaustive depletion with anti-CD25 microbeads decreased antimi-crobial responses, possibly because of removal of CD25 dim memory cells. The sorting method appears to result in cell populations that are consistently more depleted of primed alloreactive blast cells by FACS analysis and lower secondary MLR reactivity. Importantly however, we found that independent of the method of selection, a critical factor for elimination of alloreactivity is getting all the potentially alloreactive cells to become activated.
This study demonstrates that matured activated DCs facilitate recruitment to the MLR and enhance the elimination of alloreactivity. Given the primary importance of recruitment to cell division for the CFSE-based approach (and activation antigen expression for the combination sorting approach), we reasoned that the use of high relative numbers of potent APCs would be important for maximizing recruitment of alloreactive cells. Thus, we used high relative numbers of matured DCs for activating the T cells. 34 Although PBMC stimulators recruit approximately 1% of CD4 ϩ T cells to divide in an MLR, activated DCs recruit approximately 5%. More important, the sorted CFSE bright NA cells derived from DCstimulated cultures were depleted of secondary MLR reactivity. Our results indicate that PBMC-stimulated MLRs are not completely efficient and that a number of alloreactive cells do not join the proliferative reaction (up to 10% of the potentially alloreactive pool), even with an efficient purified CD4 ϩ MLR and high numbers of stimulators. Most studies of allodepletion have used PBMCs as MLR stimulators, including the only reported clinical trial of allodepletion. 21 Because residual alloreactivity correlated with GVHD, 21 we believe the extra efficiency afforded by matured DC-stimulated cultures may improve the results.
One group has used adherent cell-derived DCs, adherent cells treated with GM-CSF and IL4 and reported an 80% decrease in secondary MLR reactivity and (helper T-cell precursor) HTLp frequency. 14 We have found that adherent cell-derived DCs, although generating a robust MLR, do not as efficiently recruit all the alloreactive cells as CD14-purified derived DCs. We speculate that this occurs because of the co-purification of B cells and other cells in the adherent population. Other studies have suggested lymphoblastoid cell lines (LCLs) are better MLR stimulators for allodepletion. 15 A recent report demonstrated reduced residual proliferation in primary MLR (after immunotoxin treatment) with the use of LCL (R/S ratio of 40:1) versus PBMC stimulators. 35 By CFSE analysis, we found that the use of high numbers of LCL stimulators can lead to very high calculated precursor frequencies, possibly indicative of bystander proliferation, which we have not seen with DC-stimulated cultures.
Our work has concerned CD4 ϩ T-cell responses, both in human and mouse systems. We focused on CD4 ϩ T cells to have a more robust, consistent, and sensitive experimental system. It has proved difficult to eliminate secondary MLR reactivity, and it required the combined use of an efficient multiparameter selection strategy and purified potent APCs in high numbers to generate effective allodepletion. The resulting populations can respond proliferatively to Candida and CMV antigens and retain some ability to produce interferon-␥ in short-term Elispot assays. Transfer of allodepleted CD4 cells could provide immune protection, as CD4 ϩ T cells alone can provide direct antileukemic 36 and anti-infectious activity. 37 Of importance, CD4 ϩ T cells orchestrate immune responses by providing proinflammatory factors for activating monocytes, dendritic cells, and B cells and providing accessory factors for CD8 ϩ T-cell survival and effector differentiation.
In haploidentical BM transplantation only small numbers of allodepleted cells may need to be transferred to facilitate immune reconstitution. With the sorting approach approximately 200 million sorted CFSE bright NA cells could easily be prepared from small apheresis products (2-4 billion MNCs), as routine recovery is about 10% NA cells from total input CD4 ϩ T-cell number. Thus, a CFSE-based strategy is technically feasible in humans. Even a small number of functional T cells could help prevent EpsteinBarr virus (EBV) or CMV reactivation 38 and may provide for broad-based immune protection as well as some antitumor reactivity. 17, 18 
